Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 856 to 870 of 1433 results for primary care

  1. trublood-prostate for triaging and diagnosing people with prostate cancer symptoms (MIB268)

    NICE has developed a medtech innovation briefing (MIB) on trublood-prostate for triaging and diagnosing people with prostate cancer symptoms .

    Medtech innovation briefing
    Published
    13 July 2021

  2. Sternal Talon for sternal closure in cardiothoracic surgery (MIB88)

    NICE has developed a medtech innovation briefing (MIB) on the Sternal Talon for sternal closure in cardiothoracic surgery .

    Medtech innovation briefing
    Published
    29 November 2016

  3. Virtual ward platform technologies for acute respiratory infections: early value assessment (HTG697)

    Early value assessment (EVA) guidance on virtual ward platform technologies for acute respiratory infections.

    HealthTech guidance
    Published
    12 October 2023
    View recommendations

    Sections for HTG697

  4. Robot-assisted surgery for orthopaedic procedures: early value assessment (HTG743)

    Early value assessment (EVA) guidance on robot-assisted surgery for orthopaedic procedures.

    HealthTech guidance
    Published
    17 April 2025
    View recommendations

    Sections for HTG743

  5. Pentosan polysulfate sodium for treating bladder pain syndrome (TA610)

    Evidence-based recommendations on pentosan polysulfate sodium (Elmiron) for bladder pain syndrome in adults.

    Technology appraisal guidance
    Published
    13 November 2019
    View recommendations

    Sections for TA610

  6. Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (TA605)

    Evidence-based recommendations on Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (excessive salivation and drooling) caused by neurological conditions in adults.

    Technology appraisal guidance
    Published
    9 October 2019
    View recommendations

    Sections for TA605

  7. Lebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and over (TA986)

    Evidence-based recommendations on lebrikizumab (Ebglyss) for treating moderate to severe atopic dermatitis in people 12 years and over.

    Technology appraisal guidance
    Published
    10 July 2024
    View recommendations

    Sections for TA986

  8. gammaCore for cluster headache (HTG533)

    Evidence-based recommendations on gammaCore for cluster headache.

    HealthTech guidance
    Published
    3 December 2019
    View recommendations

    Sections for HTG533

  9. Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated (TA377)

    Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic, hormone-relapsed prostate cancer for people in whom chemotherapy is not yet clinically indicated.

    Technology appraisal guidance
    Published
    27 January 2016
    View recommendations

    Sections for TA377

  10. How does the duration and frequency of brief advice influence its effectiveness and cost effectiveness? For example, do 'micro interventions' of less than 1–2 minutes have an impact on physical activity?

    Comes from guidance Physical activity: brief advice for adults in primary care Number PH44 Date issued May 2013 Other details

    Research recommendation
    Published
    9 June 2015

  11. How can brief advice be tailored to have the greatest impact on specific groups? For example, can it be tailored to meet the needs of people of a particular gender, socioeconomic status or with a particular disability?

    Comes from guidance Physical activity: brief advice for adults in primary care Number PH44 Date issued May 2013 Other details

    Research recommendation
    Published
    9 June 2015

  12. Archimedes for biopsy of suspected lung cancer (MIB211)

    NICE has developed a medtech innovation briefing (MIB) on Archimedes for biopsy of suspected lung cancer .

    Medtech innovation briefing
    Published
    11 June 2020

  13. Selinexor with dexamethasone for treating relapsed and refractory multiple myeloma after 4 or more treatments (TA970)

    Evidence-based recommendations on selinexor (Nexpovio) with dexamethasone for treating relapsed and refractory multiple myeloma after 4 or more treatments in adults.

    Technology appraisal guidance
    Published
    8 May 2024
    View recommendations

    Sections for TA970

  14. What infrastructures and systems help increase the number of assessments of physical activity undertaken and the delivery of brief advice? (Examples studied could include integration of brief advice into long-term disease management strategies, or the use of incentive strategies.)

    Comes from guidance Physical activity: brief advice for adults in primary care Number PH44 Date issued May 2013 Other details

    Research recommendation
    Published
    9 June 2015

  15. The STAK tool for preventing and treating knee stiffness (MIB252)

    NICE has developed a medtech innovation briefing (MIB) on the STAK tool for preventing and treating knee stiffness .

    Medtech innovation briefing
    Published
    9 February 2021